Rentokil Initial Share Discussion Threads

[hedgehog 100] 01/10/2016 19:17

Nu-Oil and Gas (NUOG) 0.11p Market cap. £0.35M.




27/09/2016 16:21 UKREG Nu-Oil and Gas PLC Holding(s) in Company

"NU-Oil confirms that it was notified on 22 September 2016 that Mr Phil Terry has an interest in 20,000,000 ordinary shares in the Company, representing 6.37 per cent. of the current issued share capital.

NU-Oil also confirms that it was notified on 27 September 2016 that Mr Jack Brooks has an interest in 12,931,176 ordinary shares in the Company, representing 4.12 per cent. of the current issued share capital."

[haydock] 28/9/2016 20:04

On 3i.Re NU-oil & gas.
Not clear if this is accurate, something afoot ?
Activist shareholders

videodawn



I see the boys from New World Oil and Gas now hold more than the Minty clan and enough to call an EGM. Phil Terry looks like an activist. Some fun to watch at last?

[haydock] 23/9/2016 08:49

Something has changed in a big way this week at Nu-oil & gas.
Looks like a reverse t/o ?
No news at all & a very strange trading week.

Any hints ?

[maytrees] 22/9/2016 12:10

Many Tx Hedgehog 100 for your v. helpful reply.

[hedgehog 100] 20/9/2016 18:41

Hi Maytrees, and thanks for flagging up LVRT (Levrett).

To address your question, a RTO suspension is usually a very positive event if the RTO goes through, as it generally adds significant value.

A recent example is VLOX (outlined in the post above yours), which returned to the market as VLTY at the end of June after a RTO priced at five times the suspension price: which was a real gain, not just down to a share price consolidation.

Further back, in May 2014 ONE was suspended for a RTO, and returned a month later as BOOM at double the price.

In fact buying in just ahead of a suspension can be a good strategy if you expect a positive outcome, as the share price can be depressed beforehand by investors who don't want to be locked in, and/or are unsure of the outcome, creating a buying opportunity.

And just the potential of a suspension can create such an opportunity, even if the suspension doesn't actually happen.

However, the situation is less clear cut if there has been a very strong run up in the share price just prior to suspension.
It is possible for expectations to be too high, for the shell to be overvalued, and for it to trade lower after the RTO.
But then again it could be a deserved rerating upwards, for a shell which has previously been oversold.

You will need to assess what is fair value for the shell, and its likely deal.
And that can be very subjective and speculative, given the lack of info. you are likely to have on the RTO prior to any suspension.

[maytrees] 18/9/2016 10:36

Good morning

Having tried an experimental investment in shell LVRT a few months ago its share price stagnated for weeks at about 1.75p.

However on Thursday last week there seemed to be some interest so I added; then on Friday the share price soared to 3-4p so I took profit in half but retained a good few.

Shortly afterwards on Friday, trading was suspended pending an RTO:

"Levrett has signed a non-binding letter of intent to acquire Nuformix Limited, a UK incorporated company operating in the cocrystal technology sector, for new shares in the company. The acquisition is subject to the completion of due diligence..."

For shell co making an RTO, is the norm for the share price after completion of the RTO to be higher than the share price immediately before suspension pending completion?

In other words is it better to wait for completion or sell shares in the shell after rto rumours but b4 suspension?

[hedgehog 100] 06/9/2016 20:56

VLOX was suspended in December 2015 at 0.2p (market cap. £0.11M.) for a RTO, equivalent to a current 5p consolidation-adjusted.

And it has recently returned to market as VLTY after a RTO at 25p, a fantastic profit for anyone who bought in late last year.

This shows the merit of monitoring such micro cap tiddlers, and where appropriate, taking a punt.

Veltyco Group (VLTY) 22.5p Market cap. £12.8M.




09/06/2016 07:00 UK Regulatory (RNS & others) Velox3 PLC Proposed Acquisition and Change of Name

Proposed Acquisition of Sheltyco Enterprises Group Ltd., Change of Name to Veltyco Group plc and Notice of General Meeting

"Velox3 plc (AIM: VLOX) is pleased to announce the conditional acquisition of the entire issued share capital of Sheltyco Enterprises Group Limited for a consideration of GBP10.9 million to be satisfied by the issue of 43,753,775 new consolidated Ordinary Shares. Sheltyco is a holding company for several subsidiary companies focused on the marketing and promotion of third party online gaming, lottery and binary option operators, such as Betsafe (online casino and sports betting), Lottopalace (lottery) and Option888 (binary options).

Key points

-- Sheltyco (founded in 2011) is specialised in marketing and promotion activities in three fast growing markets:

o Online gaming (Betsafe - online casino and sports betting)

o Lottery (Lottopalace)

o Binary options (Option888)

-- Profitable and cash generative since 2013
-- Following Admission, the Enlarged Group will also review potential acquisition opportunities which fit into the company's profile.

-- The net proceeds of the transaction will be used to support the working capital needs of the Enlarged Group and to continue Sheltyco's marketing activities in gaming, lottery and binary options

-- The Directors intend to declare dividend payments as soon as it becomes commercially prudent to do so

The Company also announces that it has conditionally raised c.GBP538,000 before expenses by way of a Subscription of 2,152,172 Subscription Shares at a price per Subscription Share of 25 pence. The approximate net proceeds of the Subscription of GBP251,000 will be applied as working capital for the Enlarged Group.

The Subscription is anticipated to complete in two stages with 1,273,181 Subscription Shares being issued on Admission, raising approximately GBP318,295 (gross), and a further 878,991 Subscription Shares issued in early July raising approximately GBP219,747 (gross).

As a term of the Subscription, each Subscriber shall also receive 1 Warrant for every 5 Subscription Shares subscribed, exercisable at 31 pence per Warrant at any time during the period from the date of issue until the 5th anniversary of issue. It is not intended that the Warrants will be listed on any stock market.

In addition, the Company intends to convert outstanding loans of c.EUR818,000 into 2,717,932 Ordinary Shares and 503,586 Warrants.

Share Consolidation

The Company currently has 193,031,360 Existing Ordinary Shares in issue; the last recorded price per

Existing Ordinary Share was 0.20 pence on 4 December 2015, the last day that the Existing Ordinary Shares were trading on AIM before suspension. The Existing Directors believe that consolidating the Existing Ordinary Shares will lead to the Enlarged Group having a more readily understood share price and number of Ordinary Shares in issue.

Accordingly, the Existing Directors have decided to implement a consolidation of its share capital so that each Shareholder of every 25 or more Existing Ordinary Shares will be entitled to receive one new Ordinary Share. Shareholders with a holding in excess of 25 Existing Ordinary Shares, but which is not exactly divisible by 25, will have their holdings of Ordinary Shares rounded down to the nearest whole number of Ordinary Shares following the Share Consolidation.

Conversion of outstanding fees

In settlement of certain fees and remuneration due to the Existing Directors in the aggregate sum of EUR106,400, it is envisaged that the Board will propose to issue on Admission to David Mathewson 173,538 new Ordinary Shares and to Mark Rosman 153,846 new Ordinary Shares at the Issue Price.

Assuming that these share issues are carried out, David Mathewson's interest in the Enlarged Share Capital on Admission will comprise 249,769 Ordinary Shares representing 0.44 per cent. of the Enlarged Share Capital and warrants over 240,000 Ordinary Shares and Mark Rosman's interest will comprise 486,927 Ordinary Shares representing 0.86 per cent. of the Enlarged Share Capital.

Change of Name

To reflect the changing nature of the business the Directors propose a change of name to Veltyco Group Plc.

Notice of General Meeting

The Acquisition is classified as a reverse takeover under the AIM Rules requiring the approval of Shareholders. The Acquisition is also conditional on the approval by the Shareholders of a waiver of Rule 9 of the Takeover Code. As a result, the Company is today also publishing a readmission document (Readmission Document) which is available from the Company's website at www.velox3.com.

Conditional upon the completion of the Acquisition, application will be made for the Enlarged Issued Share Capital to be admitted to trading on AIM.

An Extraordinary General Meeting of the Company will be held at the offices of Estera Trust (Isle of Man) Limited, 33-37 Athol Street, Douglas, Isle of Man IM1 1LB on 27 June 2016 at 10.30a.m. for the purpose of considering and, if thought fit, passing the resolutions.

A copy of the Readmission Document, notice of Extraordinary General Meeting and Proxy Form will be posted to Shareholders later today

Trading in the Company's Existing Ordinary Shares on AIM is currently suspended; it is anticipated that following completion of the Acquisition the suspension will be lifted and trading in the Enlarged Share Capital will commence at 8.00 a.m. on or around 29 June 2016.

Stockdale Securities is acting as Nominated Advisor and Broker to the Company.

Capitalised terms used in this announcement but not defined have the meanings given to them in the Readmission Document."

[hedgehog 100] 01/9/2016 16:58

NEW's RTO update today makes its Big Sofa RTO sound very exciting indeed.

And NEW will have around 45% of the enlarged equity prior to any associated fundraising.

From NEW's current market cap. of £2.85M. there looks to be lots of upside.


01/09/2016 07:00 UKREG New World Oil & Gas Update on Big Sofa and AGM

"Further to the announcement on 9 May 2016, regarding the possible acquisition of Big Sofa Limited ("Big Sofa"), a company operating primarily in the high growth area of video analytics, the Company is pleased to provide an update on progress to date and other matters.

Progress with the reverse takeover of Big Sofa

The Company is continuing to make good progress with the possible reverse takeover of Big Sofa and the Board remains of the view that this acquisition is an attractive proposition for New World shareholders. Big Sofa is continuing to win new mandates from a number of leading companies and is expanding internationally, particularly in the United States where a number of its important clients are based. Big Sofa is now becoming increasingly well-established within the fast growing global video insight and analytics sector. The company has also recently made a number of key appointments and is therefore now well-resourced to capitalise on its recent contract wins and convert a number of new business opportunities. Further details on the company's progress and operations can be found on the Big Sofa website at www.bigsofa.co.uk.

New World expects to provide a further update on the transaction in due course.

Further loan to Big Sofa

Given the progress that Big Sofa has made to date, the Board has decided to provide Big Sofa with a further loan of GBP100,000, in addition to the GBP500,000 already advanced as announced on 19 July 2016, and on the same terms, in order to provide additional working capital to support this rapid growth.

Oil and gas licences

As previously reported, the Company's only remaining oil and gas asset is the Blue Creek Production Sharing Agreement in Belize, which is due to expire on 31 October 2016. The Board confirms that the Company is currently seeking to dispose or relinquish this asset. The Company has also commenced the process of dissolving the subsidiaries associated with its Danish licences which were relinquished in September 2015.

As announced on 9 May 2016, trading in the Company's shares were suspended given that the possible acquisition of Big Sofa (the "Acquisition") would amount to a reverse takeover under the AIM Rules, pending the publication of the required AIM admission document or confirmation that the Acquisition is not proceeding.

Upon completion of any disposal or expiry of the Company's existing oil and gas assets prior to the Acquisition, the Company will become an AIM Rule 15 cash shell.

Annual General Meeting

A notice convening an Annual General Meeting ("AGM") of the Company will be sent to shareholders shortly and a copy of this notice will be made available on the Company's website at www.nwoilgas.com. The principal purpose of the AGM will be for shareholders to approve the Report and Accounts for the year to 31 December 2015 (which are also available on the Company's website), and approve the adoption of a new set of articles which are more appropriate for the Company going forward."

[hedgehog 100] 07/8/2016 18:35

An appropriate name change, in view of the company's 2% interest in Horse Hill Developments Ltd:

03/08/2016 14:51 UKREG Evocutis PLC Change of Name
"Evocutis (AIM: EVO, ISDX: EVO) announces that today the name of the Company has been changed to Gunsynd plc.
As of 7am on 4 August 2016, the Company will adopt the ticker GUN.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014
The directors of Evocutis Plc accept responsibility for this announcement."


"Gunsynd (4 October 1967 – 29 April 1983) was a champion Australian Thoroughbred racehorse who won 29 races and A$280,455 in prize money. In his seven starts over one mile (1,600 metres) he was only once defeated, by half-a-head in the Epsom Handicap."

[5baggersrus] 06/8/2016 21:12

GUN is trading below cash and only 1/4 of NAV

[hedgehog 100] 06/8/2016 16:27

Very positive developments at ACO on Wednesday of this week.

Check out the premium of the placing price - a whopping 71.43% to ACO's closing share price of 8.75p on 2nd August:

03/08/2016 14:30 UK Regulatory (RNS & others) Acorn Minerals PLC Subscription

"The Company is pleased to announce that it has entered into conditional agreements with a group of unconnected investors introduced by Peterhouse Corporate Finance, pursuant to which such investors will subscribe in cash for 16,517,778 new ordinary shares in the capital of the Company (Subscription Shares) at 15p per share (Subscription Price) to raise gross proceeds of GBP2,477,666.70 (Subscriptions).

On issue, the Subscription Shares will represent 53.62% of the issued share capital as enlarged by the Subscription Shares.

The Subscription Price stands at a 71.43% premium to the closing middle market price of an ordinary share in the capital of the Company on 2 August 2016, being the latest practical date before the date of this announcement.

Completion is scheduled to take place on or before 30 September 2016 or such later date as the parties may agree. On completion the existing directors will resign and be replaced by directors nominated by the investors.

Completion of the Subscriptions is conditional upon:

-- evidence satisfactory to the investors as to the passage of resolutions at a general meeting of the Company to authorise the allotment and issue of the Subscription Shares;

-- evidence satisfactory to the investors of a prospectus relating to the issue of the Subscription Shares having been approved by the FCA; and

-- aggregate subscription monies being received by of not less than GBP2,477,666.70 (such sum having been deposited prior to exchange of the subscription agreements).

Further details will be provided in due course in a shareholder circular and in the prospectus."




Someone has big plans for this main-listed shell, and all should be unveiled shortly.

But that is not currently reflected in ACO's share price, having closed for the weekend at 11.75p, which is about the level of cash per share including the new monies.

[smart_investor] 03/8/2016 20:55

Agree Concepta is an interesting RTO. We have learned today that the team are off to China this month to sign of a deal in China. Take a look at the CPT thread for the interview link.

[hedgehog 100] 30/7/2016 21:15

Another recent health/biotech RTO which looks well worth a flutter is cancer company SALV ... especially in view of the ten-bagging of TILS.

SalvaRx Group (SALV) 23.625p Market cap. £8.6M.




03/03/2016 07:02 UK Regulatory (RNS & others) 3Legs Resources plc Reverse Takeover and Placing

"Acquisition of SalvaRx Limited

Change of name to SalvaRx Group PLC

Placing to raise GBP1.95 million

Share consolidation

Admission of Enlarged Share Capital to trading on AIM

and

Notice of General Meeting

Further to the announcement of 4 November 2015, the Company is pleased to announce that it has conditionally agreed to acquire the issued share capital not already owned by it in SalvaRx Limited ("SalvaRx") for consideration of GBP8.8 million to be satisfied by the issue of New Ordinary Shares at 35.5p per share (following a 100:1 share consolidation). The Company has also raised GBP1.95 million (before expenses) by means of a Placing of New Ordinary Shares at 35.5p per share in order to fund the Enlarged Group's further development, including its working capital needs, as well as the costs associated with the Proposals.

Highlights

-- SalvaRx operates in the field of cancer immunotherapy and its strategy is to identify, develop and finance further novel therapeutics that stimulate the immune system to fight cancer;

-- SalvaRx owns 60.49 per cent. of iOx, a company which is developing under licence a series of compounds for cancer immunotherapy;

-- SalvaRx's ownership of iOx gives the Company exposure to the fast-growing cancer immunotherapy market;

-- iOx is focused on developing its pipeline of anti-cancer treatments based on invariant natural killer T cells and has a clinical trial sponsorship agreement with Oxford University who will conduct fund, or arrange funding for, the first Phase I/II in human trial;

-- SalvaRx has a highly experienced management team who between them have a track record of developing novel drugs in cancer immunotherapy; and

-- SalvaRx is actively screening acquisitions and investments in cancer immunotherapy and complementary areas of oncology.

Richard Armstrong, Non-Executive Chairman of 3Legs commented:

"We are very pleased to have agreed the acquisition of SalvaRx, subject to shareholder approval. The business has a strong and experienced management team in the cancer immunotherapy sector which is an exciting and fast growing market."

Ian Walters, CEO of SalvaRx commented:

"Joining AIM is a major step forward for SalvaRx and allows us to fund the iOx business through to its first in human trials sponsored by Oxford University. The listing will also raise our profile as we seek to build our immunotherapy business via further acquisitions and investment opportunities.

"The iOx scientists have developed significant insights into the role of natural killer T cells in stimulating a tumour specific immune response. We believe the compounds being developed by iOx could represent a major development in cancer treatment, especially when combined with existing immuno-oncology agents, with the hope of improving the care for many different types of cancer patients."

The Acquisition is of sufficient size to constitute a reverse takeover under the AIM Rules and is therefore subject to the approval of Independent Shareholders in General Meeting.

Trading on AIM in the Existing Ordinary Shares has been suspended since 4 November 2015 due to the Company not having completed an acquisition which constitutes a reverse takeover under the AIM Rules or otherwise having implemented its investing policy within 12 months of becoming an investing company. The suspension will remain in place pending the outcome of the General Meeting.

A circular, comprising an admission document ("Admission Document") and a notice of general meeting, will be posted to Shareholders today. Defined terms in this announcement have the same meaning as those in the Admission Document.

A copy of the circular may be downloaded from the Company's website at www.3legsresources.com"



"Jim Mellon-backed biotech to join Aim
SalvaRX working on treatments using T-cells to attack tumours
MARCH 21, 2016
by: Andrew Ward, Pharmaceuticals Correspondent
An experimental cancer drug discovered at Oxford university is the focus of a new UK biotech company to be listed in London this week led by two veterans of Bristol-Myers Squibb, the large US pharmaceuticals group."

[hedgehog 100] 29/7/2016 20:15

CPT's ticker certainly has very positive connotations, after CTP's near 8-bagging over the last two and a half years or so:



CTP (Castleton Technology), formerly Redstone, certainly hasn't needed any TCP ...

"Small-cap rockets: Double or quits?
By Andrew Hore | Fri, 26th June 2015 - 15:58
... Shells surge
There are identifiable groupings in the list. For example, eight of the companies could be classed as having been shells, or about to become one, at the beginning of the period. Technology adviser MXC (MXCP) reversed into a former technology shell and is also adviser to another shell, Castleton Technology (CTP), as well as owning 24.3% of the latter. ..."
[...]

[hedgehog 100] 28/7/2016 18:44

Thanks SI.

I've only had a chance for a quick look at CPT so far, but at first glance it looks like a very interesting RTO.

Adam Reynolds certainly seems to have the golden touch!



07/07/2016 07:00 UK Regulatory (RNS & others) Frontier Resources International Acquisition, Placing & Open Offer, Change of Name

"Intention to acquire Concepta Diagnostics Limited

Placing and Open Offer to raise GBP3.5 million

Change of Name to Concepta PLC

Share Consolidation

Frontier Resources (AIM:FRI), is pleased to announce it has conditionally agreed to acquire Concepta Diagnostics Limited ("Concepta"), a pioneering UK healthcare company established in 2013, that has developed proprietary products and a platform, which targets the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility. SPARK Advisory Partners is acting as Nominated Adviser and Financial Adviser to the Company with Beaufort Securities as Broker.

Highlights of the proposed Placing, Open Offer and Acquisition
-- Raising GBP3.5million in a Placing and Open Offer

-- Frontier Resources is acquiring Concepta for GBP3.026 million comprising 30,343,950 New Ordinary Shares and GBP0.75 million in cash

-- Concepta is an innovative player in the Mobile Health and Connected Health Sector that has developed proprietary products for home self-testing as well as in a point-of-care environment

-- Concepta's products will initially address the specific needs of women with fertility issues, in particular unexplained infertility

-- MyLotus brand - unique offering allowing quantitative and qualitative measurement of a woman's personal hCG and LH hormone levels in urine samples
-- Defined route to market:

o Regulatory approvals for launch in China in place - first order from distributor with payment in advance expected following hospital testing after AIM admission

o CE-Marking for UK and Europe to follow in 2017

-- Acquisition presents an attractive market opportunity to capitalise on the Chinese and EU infertility market with annual revenue potential worth c.GBP600m

-- Proven management team with a wealth of experience in the women's health diagnostics industry

-- New Product Development growth opportunities - Concepta's proprietary platform lends itself to wider family home-health monitoring to improve individual health parameters including chronic stress, inflammation, urinary tract, healthy pregnancy progression etc ...

The Directors are proposing the Share Consolidation (whereby every 250 Existing Shares are converted into 1 New Ordinary Share) as they consider that it is in the best interests of the Company's long term development as a public quoted company to have a lower number of shares in issue and a higher nominal value such that Ordinary Shares are traded in pence rather than fractions of pence. ... "




And thanks again for flagging up NEW here.


P.S. Does anyone know what's happened to Adam Reynolds' ISDX investment vehicle HubCo Investments Ltd? -

[smart_investor] 26/7/2016 22:03

Hedge. Since we last spoke when I made you aware on NEW a potential RTO.

One for you to add to your list is Concepta Plc (CPT). Adam Reynolds latest RTO. It was newly listed today and formerly Frontier Resources.

My thread can be found here:

[dogwalker] 24/7/2016 17:06

We should all know on Thursday 28th with the Interims, Saget.

[hedgehog 100] 23/7/2016 19:14

The story of Judges Capital (since renamed Judges Scientific) is a good lesson in how shells may take quite some time to make the right deal.

Judges Capital (JDG) floated as a shell in January 2003, raising £1.8M. net after costs at 95p per share, with a market cap. of £2M. at the placing price.

26/09/2003 08:00 UK Regulatory (RNS & others) Interim Results LSE:JDG Judges Capital Plc
"Chairman's Statement
I am pleased to report for the first time to our shareholders. Your Company was floated on AIM on 7th January 2003, after raising £2m, leaving £1.8m after costs. …"


But it only made its first acquisition of a company (Fire Testing Technology) in May 2005 (with a placing at £1 per share).

By early 2014 JDG had reached about 2400p, making it a 25-bagger.

The directors of JDG had a lot of their own money invested into JDG, making them at once very incentivised and very careful.





JDG is also a good lesson in what can be some desirable RTO traits: e.g. a niche business, exporting, that owns the intellectual property.

"Judges Scientific: the precision instrument maker that came about by chance

David Cicurel explains how he built a £100m scientific instrument group after stumbling across a sector boasting 2,000 UK companies

By Alistair Osborne, Business Editor

6:00AM GMT 17 Dec 2013

… He began examining different types of deals and, among the dozens that came his way, he found one particularly “puzzling. It had £3m turnover and £750,000 operating profit, with 19 staff. It looked too good to be true.” It was FTT.

He met the owners, “an engineer and a scientist, who were both looking to retire. They explained they had a dominating position in a tiny world niche and that the drivers of the business were regulation and globalisation.

“I thought that’s a really good business to have if you have little money, you can still be powerful,” he says. “It’s better to be in a little principality and you’re the prince than competing with big empires when you don’t have the wherewithal to do that.”

Cicurel, who owns 15.6pc of Judges, wondered if FTT was a “unique thing”. So he did his “homework and found there are 2,000 companies in that sector, just in the UK”. Not only that. They export almost four-fifths of what they make.

FTT became the first of 10 acquisitions in the sector, together costing just over £30m. They have seen Judges add businesses spanning the testing of fibre optics (PFO) and soil (Global Digital Systems) to one involved in neuroscience – Scientifica, the group’s biggest purchase so far, bought this year for up to £13m.

Customers range from universities to test houses and companies. Says Cicurel: “There are two things that drive our market generally. One is education. There has been a colossal increase in university education and you have to equip these universities. The other is the fact that the world is driven by perfection and measurement - optimisation. Everything people do they try to optimise and when you optimise, you want to measure.”

Judges’s soil testing company can help construct anything from office blocks to offshore wind farms. As Cicurel explains: “People built cathedrals that are still there 10 centuries later. But there was a lot of overkill in the foundation and weight of it all. Today you build something that is much lighter and has just the foundations you need. It took more than 100 years to build Notre Dame. Today you build it in a couple of years – not that it’s nicer.”

Judges’ strategy, he says simply, is “to find good companies, very nichy, and pay down the debt. We probably see about 50 deals a year and engage seriously with three to five. They are not family businesses. I think people start them at 40 and sell them at 60. We’re normally buying because the people are getting old and want to retire.”

He always looks for certain things: a manufacturer that “owns the intellectual property”, that sells instruments scientists buy and that has good profit margins and strong exports. “If you are not exporting a lot, you are not meaningful in a world niche,” he says.

Judges’ main rivals are far bigger companies - Spectris, valued at £2.7bn, Halma (£2.1bn) and Oxford Instruments (£925m). But Cicurel ensures he has enough cash on the balance sheet to move fast on a deal, topping up the funds in October via an £8.1m placing, following the Scientifica deal.

He points out too that his big three rivals have also “done very well. I shouldn’t say this but in our sector it’s not terribly difficult to do well – though it is easy to do badly. There’s a lot of rubbish out there, you have to be really selective.”

Smiling he adds: “It’s more like mining diamonds than extracting oil.” "

[hedgehog 100] 22/7/2016 19:55

It would appier that I missed this April 2016 RTO into Eclectic Bar (BAR).

Brighton Pier (PIER) 92.5p Market cap. £29.3M.




27/04/2016 08:00 UK Regulatory (RNS & others) Brighton Pier Group PLC (The) Completion of Acquisition

"Completion of Acquisition

Readmission of the Enlarged Group to trading on AIM

The Brighton Pier Group PLC ("Brighton Pier Group", the "Company" or the "Group"), the owner of Brighton Pier and a portfolio of premium bars in the UK, is pleased to announce the admission of its Enlarged Share Capital to trading on AIM. Dealings will commence at 8.00 a.m. today under the ticker symbol AIM:PIER.

This follows the successful acquisition of The Brighton Marine Palace and Pier Company by Eclectic Bar Group Plc, the agreement of new GBP13 million debt financing with Barclays Bank plc, the renaming of the Company as The Brighton Pier Group PLC, and a placing of 15,454,546 New Ordinary Shares at the Placing Price of 55p to raise approximately GBP8.5 million (gross) for the Company, which also complete today. In addition, a further 1,853,795 Sale Shares have been sold by the Selling Shareholder, Reuben Harley, at the Placing Price pursuant to the Placing.

The Acquisition transforms the Company's business base and represents the first stage in the next phase of the Company's development, as the Group aims to create a growth company operating across a diverse portfolio of experiential leisure and entertainment assets in the UK. Brighton Pier is a profitable, cash-generative, iconic seafront visitor destination and entertainment venue attracting a broad customer base. It is estimated that the Pier attracts approximately 4.5 million visitors per annum, making it the UK's fifth most popular destination by visitor numbers. The Acquisition is expected to be immediately earnings enhancing.

Terms used in this announcement shall have the meanings given to them in the Company's admission document dated 8 April 2016 unless otherwise specified."



08/04/2016 10:54 UK Regulatory (RNS & others) Eclectic Bar Group PLC Results of Placing & Directors' dealings

"Eclectic Bar Group plc (AIM: BAR) ("Eclectic", the "Company" or, together with its Subsidiaries, the "Group") is pleased to announce the successful completion of the Placing announced earlier today (the "Placing Launch Announcement").

A total of 17,308,341 Placing Shares have been conditionally placed by Panmure Gordon and Arden Partners at a price of 55 pence per Placing Share (the "Placing Price") for a total of approximately GBP9.5 million, consisting of 15,454,546 New Ordinary Shares placed by the Company and 1,853,795 Sale Shares sold by the Selling Shareholder.

The New Ordinary Shares represent approximately 95.3 per cent. of the Existing Ordinary Shares of the Company, raising gross proceeds of approximately GBP8.5 million for the Company. The Placing Price represents a discount of 6.0 per cent. to the middle market closing price of an Ordinary Share on 7 April 2016, being the last practicable date prior to the publication of this announcement. …"

[hedgehog 100] 21/7/2016 17:54

NEW shareholders should be sitting comfortably after this RTO update two days ago:

19/07/2016 11:40 UKREG New World Oil & Gas Update on Big Sofa Limited

"The Board is pleased to announce that the second tranche of the loan to Big Sofa Limited ("Big Sofa") for working capital purposes, as described in the Company's announcement of 9 May 2016 and approved by shareholders at the Company's EGM on 17 June 2016, has now been drawn down in full. The Board is pleased with the progress that is being made by Big Sofa as regards current trading and the implementation of its strategic plan and can also confirm that the work with regard to its proposed acquisition by the Company is progressing well.

The Board is also pleased to report that Nicholas Lee has been appointed as Chairman of New World with immediate effect."

[hedgehog 100] 19/7/2016 18:24

A positive update from ACO in their final results RNS today:

19/07/2016 07:00 UKREG Acorn Minerals PLC Final Results

" … We have reviewed a number of very promising resource projects however with resources not being in favour in the capital markets it has been difficult to attract the required capital.

This sentiment is changing and we are currently carrying out due diligence reviews on several opportunities that the board believes could add significant value to shareholders. …

Whilst we have not concluded a transaction during the year we are very hopeful of doing so in the near future. This all requires considerable work by your board and on your behalf I thank my fellow directors Charles Goodfellow and Brent Fitzpatrick for their effort and commitment to this cause and I also thank you for your continuing support and look forward to updating you soon on further progress. ..."

[saget] 07/7/2016 09:52

Hi folks, I bought this share nearly twenty years ago for around £2.20 and have been waiting ever since to get my money back. Lol. Does anyone know why the share price has suddenly come out of hibernation and has motored higher?Thanking you in advance!

[hedgehog 100] 05/7/2016 19:42

Main-listed shell Acorn Minerals (ACO) has seen an explosion in volume of shares traded over the last few weeks, on rumour of an imminent deal.

At 9.875p ACO's market cap. is £1.41M.

At its last interim results it had £1.184M. cash (= 8.29p per share), no debt, and admin. costs of just £34,823 for the six months.

The volume of buying would probably have seen the share price much higher but for a pre-existing overhang which has now gone.



ACO figures for number of trades per month:

August 2015: 13
September 2015: 5
October 2015: 3
November 2015: 16
December 2015: 6
January 2016: 2
February 2016: 3
March 2016: 5
April 2016: 3
May 2016: 5
June 2016: 281

[nasdaqpat] 03/7/2016 00:10

Another Bull high of 195.4p on Friday then...your target of 230p certainly looks achievable.

[hedgehog 100] 23/6/2016 20:10

GWIK was the biggest faller yesterday when it returned from suspension after its planned RTO was aborted, and it was the biggest faller again today, down another 35% to 0.05875p, barely a third of its suspension price of 0.1675p.

LSE % Losers Top Lists
EPIC Name %
GWIK Glenwick -35%

22/06/2016 15:00 UKREG Glenwick PLC Update re Acquisition

"Glenwick announces that the suspension of trading of its ordinary shares on AIM will be lifted at 3.00pm today.

The Company's ordinary shares were suspended from trading on 23 May 2016 as it was in discussions regarding a potential acquisition which would have constituted a reverse takeover under the AIM rules for Companies. The Company is no longer engaged in discussions regarding the potential acquisition and has terminated all negotiations.

As previously announced, the Company became an investing company under AIM Rule 15 on 3rd September 2015. The Company is required to implement its investing policy within 12 months of becoming an AIM Rule 15 investing company. If this is not fulfilled, the Company will be suspended pursuant to AIM Rule 40."




GWIK's current market cap. is £1.29M. at 0.05875p.

As at 31.12.15 GWIK had net cash of £534K.

Between the year end and 9.3.16 GWIK raised a further £369K. net:

09/03/2016 07:00 UK Regulatory (RNS & others) Glenwick PLC Final Results
" ...Share issue
Since the distribution of all the net proceeds from the German property business in October and prior to the year-end, the Company raised fresh share capital of GBP640,000, providing GBP574,000 net of issue costs. Since then, the Company has raised further capital to bring these totals to GBP1,028,000 and GBP943,000 respectively. (These figures include the exercise of some warrants.) Consequently, the Company is well resourced to carry out the evaluation of investment opportunities and meet any seed funding needs which may arise. ...
"


And then on 30.3.16 it raised a further £500K. gross:

30/03/2016 13:24 UK Regulatory (RNS & others) Glenwick PLC Issue of Equity & Appointment of Consultants
"The Board of Glenwick is pleased to announce that, following further demand from professional investors, Peterhouse Corporate Finance Limited has conditionally raised GBP500,000 (before expenses) through the placing of 454,545,455 new ordinary shares of no par value each in the Company ("Placing Shares") at a price of 0.11 pence per share. ..."


That would probably add up to about £1.35 - £1.4M. of net cash, less spending since 31st. December 2015.